Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Steuber

Showing results (11-20 of 209) with videos related to

Pageof 21
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 6, 2005
Surgical management of prostate cancer: advances based on a rational approach to the dataAnoop M Meraney, Alexander Haese, Jüri Palisaar, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 13, 2023
Comparative analysis of robot-assisted and open approach for PSMA-radioguided surgery in recurrent prostate cancerFrancesca Ambrosini, Fabian Falkenbach, Lars Budäus, et al.
European Urology Focus|October 8, 2018
Metastases-yield and Prostate-specific Antigen Kinetics Following Salvage Lymph Node Dissection for Prostate Cancer: A Comparison Between Conventional Surgical Approach and Prostate-specific Membrane Antigen-radioguided SurgerySophie Knipper, Derya Tilki, Joost Mansholt, et al.
Central European Journal of Urology|December 4, 2023
PSMA PET-directed surgical metastasis-directed therapy in metachronous prostate cancerFrancesca Ambrosini, Daniel Koehler, Tarik Ghadban, et al.
Urologic Oncology|January 23, 2016
Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancerChristian P Meyer, Klaus Pantel, Pierre Tennstedt, et al.
Urologic Oncology|January 14, 2020
Definition of high-risk prostate cancer impacts oncological outcomes after radical prostatectomySophie Knipper, Pierre I Karakiewicz, Alexander Heinze, et al.
European Urology Focus|July 28, 2018
Accuracy of <sup>68</sup>Ga-Prostate-specific Membrane Antigen Positron Emission Tomography for the Detection of Lymph Node Metastases Before Salvage LymphadenectomyPhilipp Mandel, Derya Tilki, Felix K Chun, et al.
BJU International|May 26, 2021
Significant reduction of lymphoceles after radical prostatectomy and pelvic lymph node dissectionRandi M Pose, Sophie Knipper, Christoph Würnschimmel, et al.
European Urology|June 9, 2009
Current technique of open intrafascial nerve-sparing retropubic prostatectomyLars Budäus, Hendrik Isbarn, Thorsten Schlomm, et al.
The Journal of Urology|November 25, 2003
Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsiesAlexander Haese, Markus Graefen, Thomas Steuber, et al.
Pageof 21

Showing results (11-20 of 209) with videos related to

Sort By:
Pageof 21
European Journal of Cancer (Oxford, England : 1990)|April 6, 2005
Surgical management of prostate cancer: advances based on a rational approach to the dataAnoop M Meraney, Alexander Haese, Jüri Palisaar, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 13, 2023
Comparative analysis of robot-assisted and open approach for PSMA-radioguided surgery in recurrent prostate cancerFrancesca Ambrosini, Fabian Falkenbach, Lars Budäus, et al.
European Urology Focus|October 8, 2018
Metastases-yield and Prostate-specific Antigen Kinetics Following Salvage Lymph Node Dissection for Prostate Cancer: A Comparison Between Conventional Surgical Approach and Prostate-specific Membrane Antigen-radioguided SurgerySophie Knipper, Derya Tilki, Joost Mansholt, et al.
Central European Journal of Urology|December 4, 2023
PSMA PET-directed surgical metastasis-directed therapy in metachronous prostate cancerFrancesca Ambrosini, Daniel Koehler, Tarik Ghadban, et al.
Urologic Oncology|January 23, 2016
Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancerChristian P Meyer, Klaus Pantel, Pierre Tennstedt, et al.
Urologic Oncology|January 14, 2020
Definition of high-risk prostate cancer impacts oncological outcomes after radical prostatectomySophie Knipper, Pierre I Karakiewicz, Alexander Heinze, et al.
European Urology Focus|July 28, 2018
Accuracy of <sup>68</sup>Ga-Prostate-specific Membrane Antigen Positron Emission Tomography for the Detection of Lymph Node Metastases Before Salvage LymphadenectomyPhilipp Mandel, Derya Tilki, Felix K Chun, et al.
BJU International|May 26, 2021
Significant reduction of lymphoceles after radical prostatectomy and pelvic lymph node dissectionRandi M Pose, Sophie Knipper, Christoph Würnschimmel, et al.
European Urology|June 9, 2009
Current technique of open intrafascial nerve-sparing retropubic prostatectomyLars Budäus, Hendrik Isbarn, Thorsten Schlomm, et al.
The Journal of Urology|November 25, 2003
Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsiesAlexander Haese, Markus Graefen, Thomas Steuber, et al.
Pageof 21